These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29028963)

  • 1. ZCCHC17 is a master regulator of synaptic gene expression in Alzheimer's disease.
    Tomljanovic Z; Patel M; Shin W; Califano A; Teich AF
    Bioinformatics; 2018 Feb; 34(3):367-371. PubMed ID: 29028963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZCCHC17 knockdown phenocopies Alzheimer's disease-related loss of synaptic proteins and hyperexcitability.
    Cortese GP; Bartosch AMW; Xiao H; Gribkova Y; Lam TG; Argyrousi EK; Sivakumar S; Cardona C; Teich AF
    J Neuropathol Exp Neurol; 2024 Jun; 83(7):626-635. PubMed ID: 38630575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZCCHC17 Modulates Neuronal RNA Splicing and Supports Cognitive Resilience in Alzheimer's Disease.
    Bartosch AMW; Youth EHH; Hansen S; Wu Y; Buchanan HM; Kaufman ME; Xiao H; Koo SY; Ashok A; Sivakumar S; Soni RK; Dumitrescu LC; Lam TG; Ropri AS; Lee AJ; Klein HU; Vardarajan BN; Bennett DA; Young-Pearse TL; De Jager PL; Hohman TJ; Sproul AA; Teich AF
    J Neurosci; 2024 Jan; 44(3):. PubMed ID: 38050142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZCCHC17 modulates neuronal RNA splicing and supports cognitive resilience in Alzheimer's disease.
    Bartosch AMW; Youth EHH; Hansen S; Kaufman ME; Xiao H; Koo SY; Ashok A; Sivakumar S; Soni RK; Dumitrescu LC; Lam TG; Ropri AS; Lee AJ; Klein HU; Vardarajan BN; Bennett DA; Young-Pearse TL; De Jager PL; Hohman TJ; Sproul AA; Teich AF
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer's disease.
    Li X; Long J; He T; Belshaw R; Scott J
    Sci Rep; 2015 Jul; 5():12393. PubMed ID: 26202100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Condition-specific gene co-expression network mining identifies key pathways and regulators in the brain tissue of Alzheimer's disease patients.
    Xiang S; Huang Z; Wang T; Han Z; Yu CY; Ni D; Huang K; Zhang J
    BMC Med Genomics; 2018 Dec; 11(Suppl 6):115. PubMed ID: 30598117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
    Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
    Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates.
    Vargas DM; De Bastiani MA; Zimmer ER; Klamt F
    Alzheimers Res Ther; 2018 Jun; 10(1):59. PubMed ID: 29935546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic Cell Adhesion Molecules in Alzheimer's Disease.
    Leshchyns'ka I; Sytnyk V
    Neural Plast; 2016; 2016():6427537. PubMed ID: 27242933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer's disease model.
    Kim DH; Lim H; Lee D; Choi SJ; Oh W; Yang YS; Oh JS; Hwang HH; Jeon HB
    Sci Rep; 2018 Jan; 8(1):354. PubMed ID: 29321508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits.
    Yan L; Chen Y; Li W; Huang X; Badie H; Jian F; Huang T; Zhao Y; Cohen SN; Li L; Zhang YW; Luo H; Tu S; Xu H
    Sci Rep; 2016 Jan; 6():18668. PubMed ID: 26733416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease.
    Wong HK; Veremeyko T; Patel N; Lemere CA; Walsh DM; Esau C; Vanderburg C; Krichevsky AM
    Hum Mol Genet; 2013 Aug; 22(15):3077-92. PubMed ID: 23585551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease.
    Mano T; Nagata K; Nonaka T; Tarutani A; Imamura T; Hashimoto T; Bannai T; Koshi-Mano K; Tsuchida T; Ohtomo R; Takahashi-Fujigasaki J; Yamashita S; Ohyagi Y; Yamasaki R; Tsuji S; Tamaoka A; Ikeuchi T; Saido TC; Iwatsubo T; Ushijima T; Murayama S; Hasegawa M; Iwata A
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9645-E9654. PubMed ID: 29042514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cerebrovascular dysfunction with the development of Alzheimer's disease-like pathology in OXYS rats.
    Stefanova NA; Maksimova KY; Rudnitskaya EA; Muraleva NA; Kolosova NG
    BMC Genomics; 2018 Feb; 19(Suppl 3):75. PubMed ID: 29504901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAT 53: a protein phosphatase 1 nuclear targeting subunit encoded in the MHC Class I region strongly expressed in regions of the brain involved in memory, learning, and Alzheimer's disease.
    Raha-Chowdhury R; Andrews SR; Gruen JR
    Brain Res Mol Brain Res; 2005 Jul; 138(1):70-83. PubMed ID: 15894402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening novel drug candidates for Alzheimer's disease by an integrated network and transcriptome analysis.
    Peng Y; Yuan M; Xin J; Liu X; Wang J
    Bioinformatics; 2020 Nov; 36(17):4626-4632. PubMed ID: 32516365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESHRD: deconvolution of brain homogenate RNA expression data to identify cell-type-specific alterations in Alzheimer's disease.
    Piras IS; Bleul C; Talboom JS; De Both MD; Schrauwen I; Halliday G; Myers AJ; Serrano GE; Beach TG; Huentelman MJ
    Aging (Albany NY); 2020 Mar; 12(5):4124-4162. PubMed ID: 32125278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.
    Hadar A; Milanesi E; Squassina A; Niola P; Chillotti C; Pasmanik-Chor M; Yaron O; Martásek P; Rehavi M; Weissglas-Volkov D; Shomron N; Gozes I; Gurwitz D
    Transl Psychiatry; 2016 Oct; 6(10):e909. PubMed ID: 27701409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.